{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:37:22Z","timestamp":1791405442057,"version":"4.3.3"},"reference-count":50,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,1]]},"abstract":"<jats:p>Sickle cell disease (SCD), the most common genetic disease screened for in the newborn period, occurs in \u223c1 in 2400 newborns in the general population and 1 in 400 individuals of African descent in the United States. Despite the relative high prevalence and low pediatric mortality rate of SCD when compared with other genetic diseases or chronic diseases in pediatrics, few evidence-based guidelines have been developed to facilitate the transition from pediatrics to an internal medicine or family practice environment. As with any pediatric transition program, common educational, social, and health systems themes exist to prepare for the next phase of health care; however, unique features characterizing the experience of adolescents with SCD must also be addressed. These challenges include, but are not limited to, a higher proportion of SCD adolescents receiving public health insurance when compared with any other pediatric genetic or chronic diseases; the high proportion of overt strokes or silent cerebral infarcts (\u223c30%) affecting cognition; risk of low high school graduation; and a high rate of comorbid disease, including asthma. Young adults with SCD are living longer; consequently, the importance of transitioning from a pediatric primary care provider to adult primary care physician has become a critical step in the health care management plan. We identify how the primary care physicians in tandem with the pediatric specialist can enhance transition interventions for children and adolescents with SCD.<\/jats:p>","DOI":"10.1542\/peds.2011-3049","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T04:35:12Z","timestamp":1349152512000},"page":"926-935","source":"Crossref","is-referenced-by-count":108,"title":["Transition and Sickle Cell Disease"],"prefix":"10.1542","volume":"130","author":[{"given":"Michael R.","family":"DeBaun","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University School of Medicine and Monroe Carell Jr. Children\u2019s Hospital at Vanderbilt, Nashville, Tennessee; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Telfair","sequence":"additional","affiliation":[{"name":"Center for Social, Community and Health Research and Evaluation at the University of North Carolina at Greensboro, Greensboro, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"key":"2021120903555306000_B1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"11","key":"2021120903555306000_B2","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1182\/blood-2003-11-3758","article-title":"Survival of children with sickle cell disease.","volume":"103","author":"Quinn","year":"2004","journal-title":"Blood"},{"issue":"25","key":"2021120903555306000_B3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120903555306000_B4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/S0022-3476(03)00331-7","article-title":"Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.","volume":"143","author":"Adamkiewicz","year":"2003","journal-title":"J Pediatr"},{"key":"2021120903555306000_B5"},{"issue":"3","key":"2021120903555306000_B6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1542\/peds.2007-0018","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.","volume":"121","author":"Adamkiewicz","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"2021120903555306000_B7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jama.1993.03500020080036","article-title":"Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination.","volume":"269","author":"Murphy","year":"1993","journal-title":"JAMA"},{"issue":"13","key":"2021120903555306000_B8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease.","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"2021120903555306000_B9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors.","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120903555306000_B10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.2010.1026","article-title":"Transition from pediatric to adult care for patients with sickle cell disease.","volume":"304","author":"Hunt","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"2021120903555306000_B11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/IJAMH.2004.16.1.47","article-title":"Transition to adult care for adolescents with sickle cell disease: results of a national survey.","volume":"16","author":"Telfair","year":"2004","journal-title":"Int J Adolesc Med Health"},{"issue":"24","key":"2021120903555306000_B12","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMsa1013285","article-title":"Auditing access to specialty care for children with public insurance.","volume":"364","author":"Bisgaier","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120903555306000_B13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1182\/blood-2010-01-261123","article-title":"Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.","volume":"117","author":"Hulbert","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2021120903555306000_B14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(05)82150-X","article-title":"High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.","volume":"118","author":"Wang","year":"1991","journal-title":"J Pediatr"},{"issue":"3","key":"2021120903555306000_B15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1067\/mpd.2002.122498","article-title":"Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.","volume":"140","author":"Scothorn","year":"2002","journal-title":"J Pediatr"},{"issue":"17","key":"2021120903555306000_B16","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2021120903555306000_B17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpeds.2010.03.007","article-title":"Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease.","volume":"157","author":"Enninful-Eghan","year":"2010","journal-title":"J Pediatr"},{"issue":"2","key":"2021120903555306000_B18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/088307389501000203","article-title":"Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy.","volume":"10","author":"Glauser","year":"1995","journal-title":"J Child Neurol"},{"issue":"4","key":"2021120903555306000_B19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"issue":"16","key":"2021120903555306000_B20","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2011-05-349621","article-title":"Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.","volume":"119","author":"DeBaun","year":"2012","journal-title":"Blood"},{"issue":"20","key":"2021120903555306000_B21","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1182\/blood-2011-02-272682","article-title":"Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.","volume":"119","author":"DeBaun","year":"2012","journal-title":"Blood"},{"issue":"18","key":"2021120903555306000_B22","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.2010.562","article-title":"Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.","volume":"303","author":"Vichinsky","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"2021120903555306000_B23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1467-7687.2006.00503.x","article-title":"Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction.","volume":"9","author":"Hogan","year":"2006","journal-title":"Dev Sci"},{"issue":"8","key":"2021120903555306000_B24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1212\/WNL.56.8.1109","article-title":"Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease.","volume":"56","author":"Schatz","year":"2001","journal-title":"Neurology"},{"key":"2021120903555306000_B25"},{"issue":"3","key":"2021120903555306000_B26","first-page":"382","article-title":"Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit.","volume":"24","author":"Steen","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2021120903555306000_B27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archpedi.157.1.104","article-title":"Inadequate recognition of education resources required for high-risk students with sickle cell disease.","volume":"157","author":"Herron","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021120903555306000_B28","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1542\/peds.2010-1466J","article-title":"Transition planning for youth with sickle cell disease: embedding neuropsychological assessment into comprehensive care.","volume":"126","author":"Wills","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"2021120903555306000_B29","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1542\/peds.108.4.906","article-title":"Who cares for Medicaid-enrolled children with chronic conditions?","volume":"108","author":"Kuhlthau","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903555306000_B30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.21880","article-title":"Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research.","volume":"86","author":"Treadwell","year":"2011","journal-title":"Am J Hematol"},{"issue":"5","key":"2021120903555306000_B31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MPH.0b013e318211bb2e","article-title":"Growing up with sickle cell disease: a pilot study of a transition program for adolescents with sickle cell disease.","volume":"33","author":"Smith","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"2021120903555306000_B32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/pbc.21974","article-title":"Transition of patients with sickle cell disease from pediatric to adult care: assessing patient readiness.","volume":"52","author":"McPherson","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"6 pt 2","key":"2021120903555306000_B33","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1542\/peds.110.S3.1307","article-title":"Health care transition: destinations unknown.","volume":"110","author":"Reiss","year":"2002","journal-title":"Pediatrics"},{"issue":"7","key":"2021120903555306000_B34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/1054-139X(93)90143-D","article-title":"Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine.","volume":"14","author":"Blum","year":"1993","journal-title":"J Adolesc Health"},{"issue":"10","key":"2021120903555306000_B35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpedi.160.10.1079","article-title":"At what cost?","volume":"160","author":"Reiss","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"2021120903555306000_B36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1353\/hpu.2004.0049","article-title":"Providers\u2019 perspectives and beliefs regarding transition to adult care for adolescents with sickle cell disease.","volume":"15","author":"Telfair","year":"2004","journal-title":"J Health Care Poor Underserved"},{"issue":"2","key":"2021120903555306000_B37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/IJAMH.2005.17.2.169","article-title":"Multi-site study of transition in adolescents with sickle cell disease in the United Kingdom and the United States.","volume":"17","author":"Anie","year":"2005","journal-title":"Int J Adolesc Med Health"},{"key":"2021120903555306000_B38","unstructured":"Stewart D, Freeman M, Law M, et al. An evidence-based model and best practice guidelines for the transition to adulthood for youth with disabilities. The Best Journey to Adult Life for Youth with Disabilities. Canadian Association of Paediatric Health Centres; 2010. Available at www.h2o-linse.info\/xwiki\/bin\/view\/ContinuityandCoordinationofCare\/The+Best+Journey+to+Adult+Life+For+Youth+with+Disabilities. Accessed August 30, 2012"},{"issue":"6","key":"2021120903555306000_B39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pedn.2009.07.003","article-title":"Health care transitions among youth with disabilities or special health care needs: an ecological approach.","volume":"25","author":"Wang","year":"2010","journal-title":"J Pediatr Nurs"},{"issue":"1","key":"2021120903555306000_B40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1542\/peds.2004-1321","article-title":"Health care transition: youth, family, and provider perspectives.","volume":"115","author":"Reiss","year":"2005","journal-title":"Pediatrics"},{"issue":"9","key":"2021120903555306000_B41","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ajh.22098","article-title":"Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease.","volume":"86","author":"Cohen","year":"2011","journal-title":"Am J Hematol"},{"issue":"21","key":"2021120903555306000_B42","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199111213252104","article-title":"Sickle cell disease as a cause of osteonecrosis of the femoral head.","volume":"325","author":"Milner","year":"1991","journal-title":"N Engl J Med"},{"issue":"10","key":"2021120903555306000_B43","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.200708-1219OC","article-title":"Longitudinal decline in lung volume in a population of children with sickle cell disease.","volume":"178","author":"MacLean","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120903555306000_B44"},{"issue":"1","key":"2021120903555306000_B45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood-2009-06-227447","article-title":"Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation.","volume":"116","author":"Johnson","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2021120903555306000_B46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2006.09.038","article-title":"Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.","volume":"49","author":"Sachdev","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2021120903555306000_B47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2141.2011.08853.x","article-title":"Sickle cell nephropathy\u2014a practical approach.","volume":"155","author":"Sharpe","year":"2011","journal-title":"Br J Haematol"},{"issue":"6","key":"2021120903555306000_B48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2021120903555306000_B49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ajh.22016","article-title":"Transition from pediatric to adult care for sickle cell disease: results of a survey of pediatric providers.","volume":"86","author":"Sobota","year":"2011","journal-title":"Am J Hematol"},{"issue":"3","key":"2021120903555306000_B50","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-3017","article-title":"Receipt of health care transition counseling in the national survey of adult transition and health.","author":"Sawicki","year":"2011","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/130\/5\/926\/1057491\/peds_2011-3049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/130\/5\/926\/1057491\/peds_2011-3049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T20:00:35Z","timestamp":1639080035000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/130\/5\/926\/32392\/Transition-and-Sickle-Cell-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,11,1]]},"published-print":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2011-3049","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}